GTx (Fareston) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

GTx (Fareston) General Information

Description

US commercial rights of Fareston. It consist of rights to market, distribute and sell Fareston in the United States. Fareston is a pharmaceutical drug for the treatment of metastatic breast cancer in postmenopausal women.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Kyowa Kirin International
Primary Office
  • 175 Toyota Plaza
  • 7th Floor
  • Memphis, TN 38103
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GTx (Fareston) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GTx (Fareston)‘s full profile, request access.

Request a free trial

GTx (Fareston) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GTx (Fareston)‘s full profile, request access.

Request a free trial